S2Medical
S2Medical AB (publ) is a Nasdaq-listed Swedish biomed-tech innovator specializing in wound healing, infection control, and cosmeceuticals. The company develops and sells advanced solutions like Epiprotect®, IvaQ™, Instagraft®, ADMERCIN®, and Symbiovance™ to accelerate healing, combat resistant bacteria, and enhance cosmeceuticals. With a focus on innovation, research, and a holistic approach to wound care, S2Medical aims to revolutionize treatment and reduce healthcare costs.
Industries
Nr. of Employees
small (1-50)
Products
Epiprotect 21x17 cm (biosynthetic cellulose dressing)
A biosynthetic cellulose film dressing supplied in a storage solution vial, intended as a protective barrier for superficial and some full‑thickness wounds; designed to adhere, permit monitoring, control moisture and reduce dressing changes.
Epiprotect Ulcer (disc-form cellulose dressing)
An 8 cm diameter biosynthetic cellulose disc intended for acute and chronic ulcer care, designed for single application, moisture control and reduced dressing changes.
Portable single-use negative pressure therapy system
A compact, single-use negative pressure wound therapy device incorporating absorbent tubing intended to promote granulation tissue formation in deep wounds while reducing dressing changes.
Antimicrobial peptide therapeutics (AMP platform)
Research-stage antimicrobial peptide compounds and formulations intended to target multi-resistant bacteria and enhance the activity of conventional antibiotics.
Instabind (optically condensed micelle fiber material)
A fiber-based material based on optically condensed micelle fibers that is durable, washable, waterproof, self-adhesive, breathable and designed to perform similarly to silk while remaining soft.
Lyophilized type I collagen sponge (distributed product)
A sterile, lyophilized type I native collagen sponge supplied for one‑time use as an active dressing to stimulate granulation, balance absorption and humidity, and act as a barrier against infection.
Epiprotect 21x17 cm (biosynthetic cellulose dressing)
A biosynthetic cellulose film dressing supplied in a storage solution vial, intended as a protective barrier for superficial and some full‑thickness wounds; designed to adhere, permit monitoring, control moisture and reduce dressing changes.
Epiprotect Ulcer (disc-form cellulose dressing)
An 8 cm diameter biosynthetic cellulose disc intended for acute and chronic ulcer care, designed for single application, moisture control and reduced dressing changes.
Portable single-use negative pressure therapy system
A compact, single-use negative pressure wound therapy device incorporating absorbent tubing intended to promote granulation tissue formation in deep wounds while reducing dressing changes.
Antimicrobial peptide therapeutics (AMP platform)
Research-stage antimicrobial peptide compounds and formulations intended to target multi-resistant bacteria and enhance the activity of conventional antibiotics.
Instabind (optically condensed micelle fiber material)
A fiber-based material based on optically condensed micelle fibers that is durable, washable, waterproof, self-adhesive, breathable and designed to perform similarly to silk while remaining soft.
Lyophilized type I collagen sponge (distributed product)
A sterile, lyophilized type I native collagen sponge supplied for one‑time use as an active dressing to stimulate granulation, balance absorption and humidity, and act as a barrier against infection.
Services
Clinical wound-care services and consultations
Outpatient wound clinic services including assessment, treatment using in‑house wound dressings, patient education and participation in clinical studies.
R&D collaborations and translational research
Collaborative research with universities and external researchers on biomaterials, regenerative medicine and infection control to support evidence-based product development.
Commercial distribution and partner management
Management of international distributor relationships, market registrations support and regional sales coordination to place wound-care products in local healthcare markets.
Training and clinical education for product use
Provision of training and educational materials for clinicians on proper application and use of wound dressings, including support for emergency or conflict settings.
Clinical wound-care services and consultations
Outpatient wound clinic services including assessment, treatment using in‑house wound dressings, patient education and participation in clinical studies.
R&D collaborations and translational research
Collaborative research with universities and external researchers on biomaterials, regenerative medicine and infection control to support evidence-based product development.
Commercial distribution and partner management
Management of international distributor relationships, market registrations support and regional sales coordination to place wound-care products in local healthcare markets.
Training and clinical education for product use
Provision of training and educational materials for clinicians on proper application and use of wound dressings, including support for emergency or conflict settings.
Expertise Areas
- Wound healing therapies
- Burn care
- Chronic wound management
- Biomaterials development
Key Technologies
- Biosynthetic cellulose dressings
- Lyophilized type I collagen sponges
- Portable single-use negative pressure wound therapy
- Antimicrobial peptides (AMPs)